“…We describe a novel approach for percutaneous insertion of the Impella 2.5 (Abiomed Inc., Danvers, Massachusetts) through the brachial artery in 2 patients with inaccessible femoral arteries. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso